Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,293 publicly listed stocks with a combined market cap of $2.10 Trillion. R&G PharmaStudies Co. Ltd. A leads the sector with a market cap of $872.70 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$2.10 Trillion
Companies Listed
1,293
Largest Company
R&G PharmaStudies Co. …
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 301 |
R&G PharmaStudies Co. Ltd. A
SHE:301333 |
$872.70 Million | CN¥5.96 Billion | China | CN¥61.75 | -2.46% | +10.31% | 84.35 Million |
| 302 |
Jiangsu Aidea Pharmaceutical Co Ltd
SHG:688488 |
$870.04 Million | CN¥5.95 Billion | China | CN¥14.13 | -2.62% | -9.07% | 205.26 Million |
| 303 |
Immix Biopharma Inc
NASDAQ:IMMX |
$868.49 Million | $868.49 Million | USA | $12.14 | -0.57% | -12.72% | 34.66 Million |
| 304 |
Wave Life Sciences Ltd
NASDAQ:WVE |
$858.11 Million | $858.11 Million | USA | $4.46 | -2.62% | -8.23% | 80.53 Million |
| 305 |
Theravance Biopharma Inc
NASDAQ:TBPH |
$854.78 Million | $854.78 Million | USA | $17.04 | +0.06% | -0.23% | 8.97 Million |
| 306 |
WAVE LIFE SCIENCES LTD.
F:1U5 |
$854.77 Million | €731.13 Million | Germany | €3.80 | -1.17% | -4.16% | 475.00 |
| 307 |
Olema Pharmaceuticals Inc
NASDAQ:OLMA |
$854.26 Million | $854.26 Million | USA | $9.78 | -4.96% | -9.02% | 23.02 Million |
| 308 |
Alto Neuroscience, Inc.
NYSE:ANRO |
$850.38 Million | $850.38 Million | USA | $30.25 | -4.51% | -14.91% | 11.83 Million |
| 309 |
Geron Corporation
NASDAQ:GERN |
$841.64 Million | $841.64 Million | USA | $1.31 | -4.38% | -16.56% | 221.35 Million |
| 310 |
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX |
$839.53 Million | $839.53 Million | USA | $2.01 | +1.52% | -10.27% | 59.89 Million |
| 311 |
Wuhan Keqian Biology Co Ltd
SHG:688526 |
$838.29 Million | CN¥5.73 Billion | China | CN¥12.29 | -1.21% | -4.43% | 43.13 Million |
| 312 |
Inventiva S.A
PA:IVA |
$833.89 Million | €713.27 Million | France | €3.44 | +0.88% | -14.55% | 9.49 Million |
| 313 |
Theravance Biopharma Inc
F:0TB |
$828.57 Million | €708.72 Million | Germany | €14.60 | +0.00% | +0.00% | 718.00 |
| 314 |
Adlai Nortye Ltd. American Depositary Shares
NASDAQ:ANL |
$828.16 Million | $828.16 Million | USA | $15.00 | -5.84% | -0.07% | 3.99 Million |
| 315 |
Xencor Inc
NASDAQ:XNCR |
$827.65 Million | $827.65 Million | USA | $23.75 | -3.18% | -10.75% | 32.96 Million |
| 316 |
Youcare Pharmaceutical Group Co. Ltd. A
SHG:688658 |
$825.75 Million | CN¥5.64 Billion | China | CN¥12.54 | -1.72% | -5.50% | 449.52 Million |
| 317 |
Kalvista Pharmaceuticals Inc
NASDAQ:KALV |
$820.37 Million | $820.37 Million | USA | $27.00 | +0.00% | +0.19% | 70.92 Million |
| 318 |
Shanghai Haohai Biological Tech Co
SHG:688366 |
$801.86 Million | CN¥5.48 Billion | China | CN¥28.81 | -1.03% | -4.57% | 15.49 Million |
| 319 |
Climb Bio Inc
NASDAQ:CLYM |
$798.94 Million | $798.94 Million | USA | $13.91 | -4.46% | -10.37% | 38.21 Million |
| 320 |
Medincell SA
PA:MEDCL |
$790.73 Million | €676.36 Million | France | €21.40 | -1.74% | -6.14% | 1.40 Million |
| 321 |
Hangzhou Biotest Biotech Co Ltd
SHG:688767 |
$789.08 Million | CN¥5.39 Billion | China | CN¥36.11 | -2.22% | -7.27% | 50.70 Million |
| 322 |
BIOCYTOGEN PHARMA. H YC1
F:I54 |
$785.50 Million | €671.88 Million | Germany | €6.25 | -3.85% | -2.34% | 0.00 |
| 323 |
Rigel Pharmaceuticals Inc
NASDAQ:RIGL |
$782.13 Million | $782.13 Million | USA | $44.36 | -2.18% | -8.86% | 6.73 Million |
| 324 |
PharmaResources (Shanghai) Co. Ltd. A
SHE:301230 |
$775.26 Million | CN¥5.30 Billion | China | CN¥29.28 | -1.78% | -2.66% | 397.60 Million |
| 325 |
Silence Therapeutics PLC
NASDAQ:SLN |
$774.44 Million | $774.44 Million | USA | $12.46 | -4.59% | -14.60% | 25.30 Million |
| 326 |
Replimune Group Inc
NASDAQ:REPL |
$762.97 Million | $762.97 Million | USA | $13.03 | -0.61% | -13.36% | 63.91 Million |
| 327 |
PHARMING GRP SP. ADRS
F:PHG |
$762.66 Million | €652.34 Million | Germany | €13.90 | -0.71% | -4.79% | 447.00 |
| 328 |
Supriya Lifescience Limited
NSE:SUPRIYA |
$761.55 Million | Rs70.42 Billion | India | Rs874.95 | -2.97% | +2.59% | 8.68 Million |
| 329 |
Gubra A/S
CO:GUBRA |
$758.45 Million | Dkr4.85 Billion | Denmark | Dkr296.80 | -4.87% | -17.23% | 817.00K |
| 330 |
Pharming Group NV
NASDAQ:PHAR |
$745.10 Million | $745.10 Million | USA | $10.55 | -2.50% | -6.06% | 457.74K |
| 331 |
Pharming Group NV
AS:PHARM |
$741.20 Million | €633.99 Million | Netherlands | €0.91 | -2.72% | -7.33% | 157.38 Million |
| 332 |
DBV Technologies
NASDAQ:DBVT |
$739.10 Million | $739.10 Million | USA | $11.76 | -4.78% | -12.69% | 6.54 Million |
| 333 |
GH RESEARCH PLC DL-025
F:1KA |
$737.24 Million | €630.60 Million | Germany | €24.00 | +3.45% | +1.69% | 500.00 |
| 334 |
ORUM
KQ:475830 |
$726.64 Million | ₩1.07 Trillion | Korea | ₩50500.00 | +1.10% | -6.65% | 2.81 Million |
| 335 |
Astria Therapeutics Inc
NASDAQ:ATXS |
$718.13 Million | $718.13 Million | USA | $5873.65 | +10.87% | +47002.25% | 16.63 Million |
| 336 |
DBV Technologies S.A.
PA:DBV |
$716.13 Million | €612.54 Million | France | €2.07 | -3.63% | -11.01% | 26.19 Million |
| 337 |
Nuvectis Pharma Inc
NASDAQ:NVCT |
$715.56 Million | $715.56 Million | USA | $21.92 | -6.12% | -10.49% | 4.57 Million |
| 338 |
XOMA Royalty Corporation
NASDAQ:XOMA |
$710.16 Million | $710.16 Million | USA | $40.17 | +0.00% | -8.39% | 8.18 Million |
| 339 |
DNA Link Inc
KQ:127120 |
$708.38 Million | ₩1.05 Trillion | Korea | ₩30300.00 | +0.66% | -6.48% | 3.71 Million |
| 340 |
Monopar Therapeutics Inc
NASDAQ:MNPR |
$700.28 Million | $700.28 Million | USA | $104.33 | -3.68% | -11.25% | 3.94 Million |
| 341 |
MiMedx Group Inc
NASDAQ:MDXG |
$699.04 Million | $699.04 Million | USA | $4.72 | +1.72% | +3.28% | 23.77 Million |
| 342 |
Crescent Biopharma, Inc.
NASDAQ:CBIO |
$698.31 Million | $698.31 Million | USA | $18.80 | -4.47% | -9.96% | 6.38 Million |
| 343 |
Guangzhou Boji Medical and Biotechnological Co Ltd
SHE:300404 |
$698.25 Million | CN¥4.77 Billion | China | CN¥12.37 | -2.06% | -3.36% | 1.21 Billion |
| 344 |
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197 |
$697.70 Million | CN¥4.77 Billion | China | CN¥32.06 | -2.38% | -3.81% | 61.98 Million |
| 345 |
Basilea Pharmaceutica AG
SW:BSLN |
$686.09 Million | CHF542.68 Million | Switzerland | CHF65.40 | -1.06% | +4.47% | 1.51 Million |
| 346 |
Aura Biosciences Inc
NASDAQ:AURA |
$683.95 Million | $683.95 Million | USA | $6.92 | -1.28% | -8.47% | 19.58 Million |
| 347 |
Sunmax Biotechnology Co Ltd
TWO:4728 |
$677.77 Million | NT$21.51 Billion | Taiwan | NT$395.00 | -1.25% | -2.47% | 140.24K |
| 348 |
Genfit S.A.
PA:GNFT |
$674.30 Million | €576.76 Million | France | €11.76 | -5.77% | -13.40% | 6.23 Million |
| 349 |
Neurogene Inc
NASDAQ:NGNE |
$672.13 Million | $672.13 Million | USA | $33.69 | -4.32% | -12.72% | 5.13 Million |
| 350 |
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880 |
$670.40 Million | CN¥4.58 Billion | China | CN¥20.20 | -2.13% | -12.86% | 97.50 Million |
| 351 |
Wecome Pharmaceutical Co Ltd
SHE:300878 |
$667.40 Million | CN¥4.56 Billion | China | CN¥31.50 | -5.97% | -7.57% | 75.88 Million |
| 352 |
Verastem Inc
NASDAQ:VSTM |
$664.74 Million | $664.74 Million | USA | $7.34 | -2.26% | -10.49% | 50.63 Million |
| 353 |
Beijing Konruns Pharmaceutical Co Ltd
SHG:603590 |
$659.89 Million | CN¥4.51 Billion | China | CN¥28.36 | -1.32% | -6.31% | 63.93 Million |
| 354 |
Oneness Biotech Co Ltd
TWO:4743 |
$655.67 Million | NT$20.81 Billion | Taiwan | NT$43.50 | +0.12% | -4.61% | 31.36 Million |
| 355 |
ABBISKO CAYMAN DL-00001
F:8ZD |
$653.62 Million | €559.08 Million | Germany | €0.94 | -0.53% | -2.08% | 0.00 |
| 356 |
Sagimet Biosciences Inc. Series A Common Stock
NASDAQ:SGMT |
$644.24 Million | $644.24 Million | USA | $10.46 | -3.86% | -4.39% | 26.49 Million |
| 357 |
Sinovac Biotech Ltd
NASDAQ:SVA |
$642.44 Million | $642.44 Million | USA | $6.47 | +0.00% | +0.00% | 0.00 |
| 358 |
Annexon Inc
NASDAQ:ANNX |
$642.26 Million | $642.26 Million | USA | $3.92 | -0.76% | -19.51% | 65.67 Million |
| 359 |
ChemPartner PharmaTech Co Ltd
SHE:300149 |
$641.24 Million | CN¥4.38 Billion | China | CN¥8.80 | -2.44% | -2.11% | 719.71 Million |
| 360 |
BlossomHill Therapeutics, Inc. Common Stock
NASDAQ:BLSM |
$639.79 Million | $639.79 Million | USA | $22.17 | +1.98% | +0.73% | 4.55 Million |
| 361 |
Achieve Life Sciences Inc
NASDAQ:ACHV |
$639.57 Million | $639.57 Million | USA | $7.32 | +1.24% | -13.78% | 38.68 Million |
| 362 |
Phathom Pharmaceuticals Inc
NASDAQ:PHAT |
$636.59 Million | $636.59 Million | USA | $8.16 | -5.99% | -14.11% | 26.48 Million |
| 363 |
EirGenix
TWO:6589 |
$632.48 Million | NT$20.08 Billion | Taiwan | NT$66.40 | +0.00% | +0.00% | 579.36K |
| 364 |
Wuhan Hvsen Biotechnology Co Ltd
SHE:300871 |
$629.52 Million | CN¥4.30 Billion | China | CN¥21.32 | -0.56% | -6.24% | 131.59 Million |
| 365 |
Medigen Vaccine Biologics
TWO:6547 |
$618.34 Million | NT$19.63 Billion | Taiwan | NT$59.70 | +2.75% | -5.84% | 152.11 Million |
| 366 |
Xiangxue Pharmaceutical
SHE:300147 |
$615.43 Million | CN¥4.21 Billion | China | CN¥6.36 | +0.32% | +0.00% | 225.64 Million |
| 367 |
Alpha Tau Medical Ltd
NASDAQ:DRTS |
$614.75 Million | $614.75 Million | USA | $14.87 | +3.26% | -1.06% | 14.44 Million |
| 368 |
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued
NASDAQ:TRAXV |
$613.49 Million | $613.49 Million | USA | $17.66 | +3.55% | -3.37% | 11.17 Million |
| 369 |
Gyre Therapeutics Inc.
NASDAQ:GYRE |
$610.31 Million | $610.31 Million | USA | $6.69 | -0.59% | +5.19% | 1.62 Million |
| 370 |
CorMedix Inc
NASDAQ:CRMD |
$600.87 Million | $600.87 Million | USA | $7.76 | -1.65% | -7.95% | 32.55 Million |
| 371 |
Anhui Huaheng Biotechnology Co. Ltd. A
SHG:688639 |
$598.04 Million | CN¥4.09 Billion | China | CN¥16.34 | -1.57% | -8.87% | 130.13 Million |
| 372 |
Candel Therapeutics Inc
NASDAQ:CADL |
$597.89 Million | $597.89 Million | USA | $11.12 | +4.17% | -12.99% | 32.53 Million |
| 373 |
Bright Minds Biosciences Inc
NASDAQ:DRUG |
$590.88 Million | $590.88 Million | USA | $60.22 | -4.99% | -7.58% | 2.52 Million |
| 374 |
Assembly Biosciences Inc
NASDAQ:ASMB |
$589.64 Million | $589.64 Million | USA | $28.96 | -2.82% | -21.13% | 7.79 Million |
| 375 |
CytomX Therapeutics Inc
NASDAQ:CTMX |
$586.15 Million | $586.15 Million | USA | $2.69 | -15.94% | -27.49% | 78.62 Million |
| 376 |
Oculis Holding AG Ordinary shares
NASDAQ:OCS |
$583.90 Million | $583.90 Million | USA | $10.07 | -5.00% | -17.26% | 3.96 Million |
| 377 |
Clarity Pharmaceuticals Ltd
AU:CU6 |
$576.84 Million | AU$815.25 Million | Australia | AU$2.19 | +2.34% | -3.52% | 43.32 Million |
| 378 |
Achieve Life Sciences Inc
F:SP4P |
$574.89 Million | €491.74 Million | Germany | €6.15 | -0.81% | -14.58% | 0.00 |
| 379 |
OmniAb Inc.
NASDAQ:OABI |
$574.29 Million | $574.29 Million | USA | $4.35 | -2.90% | +0.46% | 56.81 Million |
| 380 |
SHANGHAI JUNSHI BIO YC1
F:8SJ |
$572.11 Million | €489.36 Million | Germany | €1.88 | -0.53% | -2.59% | 0.00 |
| 381 |
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
$570.99 Million | CN¥3.90 Billion | China | CN¥3.79 | -2.57% | -1.04% | 1.28 Billion |
| 382 |
Beijing Bohui Innovation Technology Co Ltd
SHE:300318 |
$570.20 Million | CN¥3.90 Billion | China | CN¥4.77 | -3.44% | -6.10% | 258.67 Million |
| 383 |
Prime Medicine, Inc. Common Stock
NASDAQ:PRME |
$569.52 Million | $569.52 Million | USA | $3.14 | -1.26% | -15.14% | 62.18 Million |
| 384 |
Regulus Therapeutics Inc
NASDAQ:RGLS |
$564.95 Million | $564.95 Million | USA | $8.16 | +0.00% | +0.00% | 9.34 Million |
| 385 |
ASYMCHEM LAB.(TIAN.)H YC1
F:7K90 |
$559.71 Million | €478.75 Million | Germany | €17.20 | +4.24% | +21.13% | 0.00 |
| 386 |
Qurient Co. Ltd
KQ:115180 |
$551.77 Million | ₩814.20 Billion | Korea | ₩21850.00 | -1.13% | -15.15% | 5.76 Million |
| 387 |
Hefei Lifeon Pharmaceutical Co Ltd
SHE:003020 |
$550.36 Million | CN¥3.76 Billion | China | CN¥16.48 | -1.49% | -7.00% | 174.33 Million |
| 388 |
Sage Therapeutics Inc
NASDAQ:SAGE |
$544.94 Million | $544.94 Million | USA | $8.68 | +0.00% | +0.00% | 0.00 |
| 389 |
Arvinas Inc
NASDAQ:ARVN |
$540.09 Million | $540.09 Million | USA | $8.26 | -1.67% | -12.03% | 17.38 Million |
| 390 |
Tectonic Therapeutic, Inc.
NASDAQ:TECX |
$537.96 Million | $537.96 Million | USA | $28.51 | -4.04% | -7.28% | 5.56 Million |
| 391 |
Beijing Scitop Bio Tech Co Ltd
SHE:300858 |
$532.87 Million | CN¥3.64 Billion | China | CN¥13.82 | -0.07% | -6.43% | 119.28 Million |
| 392 |
MapLight Therapeutics, Inc. Common Stock
NASDAQ:MPLT |
$527.30 Million | $527.30 Million | USA | $12.08 | -8.14% | -12.27% | 13.72 Million |
| 393 |
Regenxbio Inc
NASDAQ:RGNX |
$524.47 Million | $524.47 Million | USA | $7.95 | -8.57% | -11.13% | 30.09 Million |
| 394 |
Assure Tech Hangzhou Co Ltd
SHG:688075 |
$519.76 Million | CN¥3.55 Billion | China | CN¥27.95 | -1.06% | -6.18% | 12.82 Million |
| 395 |
Lifecome Biochemistry Co Ltd
SHE:002868 |
$518.52 Million | CN¥3.54 Billion | China | CN¥22.80 | -0.13% | -11.25% | 95.12 Million |
| 396 |
Zevra Therapeutics Inc.
NASDAQ:ZVRA |
$516.25 Million | $516.25 Million | USA | $12.05 | +0.33% | -2.03% | 19.43 Million |
| 397 |
4D Molecular Therapeutics Inc
NASDAQ:FDMT |
$515.62 Million | $515.62 Million | USA | $13.63 | -0.94% | -8.95% | 23.90 Million |
| 398 |
Pulike Biological Engineering
SHG:603566 |
$515.51 Million | CN¥3.52 Billion | China | CN¥10.18 | -1.74% | -4.77% | 72.41 Million |
| 399 |
Eikon Therapeutics, Inc. Common Stock
NASDAQ:EIKN |
$513.78 Million | $513.78 Million | USA | $9.49 | +1.39% | -12.62% | 13.06 Million |
| 400 |
OPTHEA LTD (SP.ADR/8)
F:UKJ2 |
$512.99 Million | €438.79 Million | Germany | €3.00 | +0.00% | +0.00% | 0.00 |
| 401 |
TaiMed Biologics
TWO:4147 |
$508.31 Million | NT$16.13 Billion | Taiwan | NT$59.60 | -0.50% | -4.94% | 24.12 Million |
| 402 |
Autolus Therapeutics Ltd
NASDAQ:AUTL |
$503.01 Million | $503.01 Million | USA | $1.89 | -2.58% | -15.63% | 53.97 Million |
| 403 |
CHA Biotech Co. Ltd
KQ:085660 |
$500.88 Million | ₩739.11 Billion | Korea | ₩7950.00 | +0.13% | -1.73% | 7.56 Million |
| 404 |
Capricor Therapeutics Inc
NASDAQ:CAPR |
$495.73 Million | $495.73 Million | USA | $8.56 | -2.84% | -8.94% | 228.49 Million |
| 405 |
Valneva SE
PA:VLA |
$494.26 Million | €422.77 Million | France | €2.82 | -1.91% | -2.39% | 32.79 Million |
| 406 |
Ovid Therapeutics Inc
NASDAQ:OVID |
$489.00 Million | $489.00 Million | USA | $2.71 | -1.09% | -3.21% | 34.48 Million |
| 407 |
AgomAb Therapeutics NV American Depositary Shares
NASDAQ:AGMB |
$488.54 Million | $488.54 Million | USA | $12.16 | -0.98% | -22.94% | 3.81 Million |
| 408 |
Shanghai Shen Lian Biomedical Corp
SHG:688098 |
$479.52 Million | CN¥3.28 Billion | China | CN¥7.98 | -0.87% | -3.86% | 82.87 Million |
| 409 |
Autolus Therapeutics plc
F:6A3A |
$479.09 Million | €409.79 Million | Germany | €1.65 | +3.77% | -15.38% | 0.00 |
| 410 |
Eupraxia Pharmaceuticals Inc. Common Stock
NASDAQ:EPRX |
$467.26 Million | $467.26 Million | USA | $8.11 | +0.50% | -3.45% | 11.67 Million |
| 411 |
Relmada Therapeutics Inc
NASDAQ:RLMD |
$465.71 Million | $465.71 Million | USA | $4.44 | +0.00% | +0.23% | 28.28 Million |
| 412 |
I-Mab
NASDAQ:IMAB |
$456.45 Million | $456.45 Million | USA | $3.96 | -1.74% | +0.25% | 11.39 Million |
| 413 |
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM |
$455.49 Million | $455.49 Million | USA | $13.82 | -6.75% | -17.25% | 12.15 Million |
| 414 |
Qingdao Vland Biotech Co Ltd
SHG:603739 |
$453.20 Million | CN¥3.10 Billion | China | CN¥12.24 | -2.70% | -6.13% | 146.52 Million |
| 415 |
Iteos Therapeutics Inc
NASDAQ:ITOS |
$448.68 Million | $448.68 Million | USA | $10.15 | +0.00% | +0.00% | 0.00 |
| 416 |
Prothena Corporation plc
NASDAQ:PRTA |
$448.40 Million | $448.40 Million | USA | $8.33 | -5.98% | -15.17% | 7.98 Million |
| 417 |
Shanghai Model Organisms Center Inc
SHG:688265 |
$445.05 Million | CN¥3.04 Billion | China | CN¥39.01 | -1.66% | +0.75% | 67.12 Million |
| 418 |
Vogenx Inc Common Stock
NASDAQ:VOGX |
$442.68 Million | $442.68 Million | USA | $32.21 | -0.65% | +1.51% | 2.56 Million |
| 419 |
Pharmicell
KO:005690 |
$441.61 Million | ₩651.64 Billion | Korea | ₩10860.00 | -0.91% | +1.12% | 25.78 Million |
| 420 |
Cabaletta Bio Inc
NASDAQ:CABA |
$439.97 Million | $439.97 Million | USA | $2.60 | -10.82% | -25.22% | 127.61 Million |
| 421 |
VALNEVA SE SP.ADS/2
F:AYJ0 |
$438.08 Million | €374.72 Million | Germany | €5.10 | -9.73% | -12.07% | 0.00 |
| 422 |
ENTERA BIO IS-0000769
F:5DT |
$432.85 Million | €370.24 Million | Germany | €2.38 | +2.59% | -9.85% | 4.80K |
| 423 |
Design Therapeutics Inc
NASDAQ:DSGN |
$430.65 Million | $430.65 Million | USA | $12.23 | -9.58% | -19.25% | 15.44 Million |
| 424 |
Hinova Pharmaceuticals Inc. A
SHG:688302 |
$428.15 Million | CN¥2.93 Billion | China | CN¥29.55 | -0.57% | -4.71% | 39.21 Million |
| 425 |
Baolingbao Biology Co Ltd
SHE:002286 |
$426.47 Million | CN¥2.91 Billion | China | CN¥7.67 | -4.96% | -8.80% | 422.77 Million |
| 426 |
Kyverna Therapeutics, Inc. Common Stock
NASDAQ:KYTX |
$423.13 Million | $423.13 Million | USA | $6.96 | -5.95% | -15.64% | 18.08 Million |
| 427 |
PureTech Health PLC
NASDAQ:PRTC |
$423.06 Million | $423.06 Million | USA | $17.38 | +4.51% | +4.95% | 97.99K |
| 428 |
ARS Pharmaceuticals, Inc
NASDAQ:SPRY |
$422.03 Million | $422.03 Million | USA | $4.25 | -5.56% | -24.38% | 41.58 Million |
| 429 |
C4 Therapeutics Inc
NASDAQ:CCCC |
$421.98 Million | $421.98 Million | USA | $3.43 | +0.00% | -8.78% | 51.32 Million |
| 430 |
Benitec Biopharma Ltd ADR
NASDAQ:BNTC |
$420.65 Million | $420.65 Million | USA | $12.70 | -2.01% | -6.62% | 3.18 Million |
| 431 |
Hyundai Bioscience Co. Ltd
KQ:048410 |
$419.86 Million | ₩619.55 Billion | Korea | ₩6420.00 | -2.87% | +2.23% | 31.51 Million |
| 432 |
Beijing Kawin Technology Share-holding Co Ltd
SHG:688687 |
$419.74 Million | CN¥2.87 Billion | China | CN¥16.78 | -2.10% | -5.36% | 77.03 Million |
| 433 |
Guanhao Biotech Co Ltd
SHE:300238 |
$418.66 Million | CN¥2.86 Billion | China | CN¥10.79 | -2.00% | -6.74% | 141.90 Million |
| 434 |
Atea Pharmaceuticals Inc
NASDAQ:AVIR |
$415.46 Million | $415.46 Million | USA | $5.23 | -1.69% | -10.29% | 6.06 Million |
| 435 |
Altimmune Inc
NASDAQ:ALT |
$413.26 Million | $413.26 Million | USA | $3.30 | +0.92% | +0.61% | 96.64 Million |
| 436 |
Apellis Pharmaceuticals Inc
NASDAQ:APLS |
$412.48 Million | $412.48 Million | USA | $3.22 | +3.29% | -2.22% | 1.91K |
| 437 |
Eupraxia Pharmaceuticals Inc
TO:EPRX |
$410.35 Million | CA$567.26 Million | Canada | CA$11.20 | -0.09% | -3.78% | 1.64 Million |
| 438 |
Zhejiang Shouxiangu Pharm Co
SHG:603896 |
$408.45 Million | CN¥2.79 Billion | China | CN¥14.08 | -1.95% | -5.25% | 44.50 Million |
| 439 |
Hansa Biopharma AB
ST:HNSA |
$405.89 Million | Skr3.77 Billion | Sweden | Skr37.82 | -4.88% | -18.07% | 13.72 Million |
| 440 |
Editas Medicine Inc
NASDAQ:EDIT |
$403.92 Million | $403.92 Million | USA | $2.63 | -4.01% | -18.58% | 61.15 Million |
| 441 |
Nanhua Bio Medicine Co Ltd
SHE:000504 |
$403.24 Million | CN¥2.76 Billion | China | CN¥8.35 | -2.91% | -2.91% | 137.84 Million |
| 442 |
Larimar Therapeutics Inc
NASDAQ:LRMR |
$402.03 Million | $402.03 Million | USA | $3.91 | +3.44% | +2.09% | 23.19 Million |
| 443 |
Rezolute Inc
NASDAQ:RZLT |
$399.61 Million | $399.61 Million | USA | $4.15 | -2.35% | -9.39% | 31.63 Million |
| 444 |
Egetis Therapeutics AB (publ)
ST:EGTX |
$393.78 Million | Skr3.66 Billion | Sweden | Skr7.87 | -1.13% | +2.88% | 19.50 Million |
| 445 |
Guangdong VTR Bio-Tech Co Ltd
SHE:300381 |
$392.34 Million | CN¥2.68 Billion | China | CN¥5.46 | -3.87% | -2.15% | 297.33 Million |
| 446 |
Y mAbs Therapeutics
NASDAQ:YMAB |
$391.22 Million | $391.22 Million | USA | $8.61 | +0.00% | +0.00% | 760.67K |
| 447 |
BridgeBio Oncology Therapeutics, Inc.
NASDAQ:BBOT |
$390.92 Million | $390.92 Million | USA | $4.88 | -3.37% | -45.66% | 12.28 Million |
| 448 |
Allogene Therapeutics Inc
NASDAQ:ALLO |
$386.54 Million | $386.54 Million | USA | $1.72 | -3.37% | -12.69% | 122.54 Million |
| 449 |
Turn Therapeutics Inc. Common Stock
NASDAQ:TTRX |
$384.46 Million | $384.46 Million | USA | $13.46 | +0.07% | +37.35% | 2.06 Million |
| 450 |
Opus Genetics, Inc.
NASDAQ:IRD |
$382.72 Million | $382.72 Million | USA | $5.82 | -2.51% | +24.63% | 95.21 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries